CellRapeutics™ Leukopak from Atopic Dermatitis Donor (XS-0426-XU229)

Name: CellRapeutics™ Leukopak from Atopic Dermatitis Donor
SKU: XS-0426-XU229
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product features a concentrated leucocyte population from donors suffering from Atopic Dermatitis. The Leukopak is rich in skin-homing T cells and inflammatory dendritic cells that drive the "itch-scratch" cycle and skin barrier dysfunction. It provides a robust platform for investigating the systemic immune dysregulation that underlies chronic cutaneous inflammation and type 2 immune responses.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Atopic Dermatitis Donor

Cat. No.
XS-0426-XU229

Donor Age
Young Adult

Donor Health
Donors exhibit systemic allergic dysregulation. The leukocyte profile is characterized by expanded skin-homing lymphocyte subsets and altered innate immune cell activity related to epidermal barrier dysfunction.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose or Heparin, selected to preserve the skin-homing markers on T cells and ensure high post-thaw recovery.

Additional Donor Information
Each lot features a Leukopak from donors with moderate-to-severe eczema. Profiles include EASI scores and history of systemic treatments.

Clinical Profile
Eczema Area and Severity Index score, age of onset, and history of other atopic conditions.

Additional Information

Medication History
Available upon request. Documentation of topical/systemic corticosteroids, calcineurin inhibitors, and history of biological agents.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Atopic Dermatitis Donor, Leukopak, Atopic Dermatitis

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Atopic Dermatitis Donor (XS-0426-XU229). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.